In the past ten years women's health research has developed its current approach which treats female health through comprehensive medical methods. The discussion revolves around the flibanserin 100 mg tablet which became the first FDA-approved non-hormonal treatment for acquired generalized HSDD in premenopausal women. The field contains its most essential yet frequently neglected segment which focuses on treating Female Sexual Dysfunction (FSD) through the study of Hypoacti
